The results suggested that COSM regulated the LPS/TLR4/NF-κB inflammatory pathway by changing the intestinal flora structure and intestinal barrier and ultimately affected NAFLD progression. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.